Takeda Pharmaceutical Co. Ltd., 10% Owner at Phathom Pharmaceuticals, Inc. (PHAT), sold 18 shares at $19.00 ($342) on 2022-03-14, disclosed to the SEC on 2022-03-16.
Open-market sale of $342 PHAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |
| PHAT | SELL | 2021-07-06 | $582K | — | Filing → |